This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Elephas Biosciences Corporation. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Innovator Spotlight: Neil Anthony and His Contributions to Drug Response Predictability
Introduction: Neil Anthony is a prominent inventor based in Decatur, GA, who has made significant strides in the field of pharmacology. With a focus on enhancing the predictability of drug responses in tissues, his innovative work has implications for both research and clinical applications.
Latest Patents: Neil holds a patent for "Ex vivo systems and methods for determining the effect of a drug or other agent on a tissue." This patent encompasses systems and methods that predict the response of a drug or other agent on the tissue. He developed techniques that involve cutting tissue into fragments, administering a drug based on estimated tumor content, and measuring the tissue fragments' response ex vivo.
Career Highlights: Neil Anthony is associated with Elephas Biosciences Corporation, where he applies his expertise to advance the company's mission in drug response predictability research. His single patent reflects not only his innovative spirit but also his commitment to improving patient outcomes through scientific research.
Collaborations: At Elephas Biosciences Corporation, Neil collaborates with talented professionals such as Jonathan Daniel Oliner and Sean Caenepeel. Together, they leverage their combined expertise to push the boundaries of research in the medical field.
Conclusion: Neil Anthony is a dedicated inventor whose pioneering work in ex vivo systems has the potential to revolutionize how we understand drug responses on tissues. His contributions not only exemplify innovation but also underscore the importance of collaboration in driving scientific advancements.